Transient prenatal ruxolitinib treatment promotes neurogenesis and suppresses astrogliogenesis during embryonic mouse brain development

Ruxolitinib is a Janus kinase (JAK) inhibitor that inhibits the JAK/STAT signalling pathway by targeting JAK1 and JAK2, which are crucial for regulating astrogliogenesis. This study assessed the effect of ruxolitinib (5 and 30 mg/kg/day) on developing mouse brains by administering it to pregnant mic...

Full description

Bibliographic Details

Main Authors:	Abdullah, Amirah Nabilah, Fasihah Zamri, Auni, Alias, Khairunnisa, Azhar, Nur Munawwarah, Ling, King Hwa, Cheah, Pike See, Zainal Abidin, Shahidee
Format:	Article
Language:	en
Published:	Neurotak Publishing 2025
Online Access:	http://psasir.upm.edu.my/id/eprint/118733/1/118733.pdf http://psasir.upm.edu.my/id/eprint/118733/ https://neuroscirn.org/ojs/index.php/nrnotes/article/view/352
Tags:	Add Tag No Tags, Be the first to tag this record!